Final hours! Save up to 55% OFF InvestingProCLAIM SALE

UnitedHealth agrees to sell Brazil operations to Qualicorp founder

Published 12/29/2023, 07:26 AM
Updated 12/29/2023, 10:56 AM
© Reuters.
UNH
-

(Reuters) -UnitedHealth Group said on Friday it had agreed to sell its operations in Brazil to the founder and former CEO of health insurance firm Qualicorp José Seripieri Filho.

Last week, two sources had told Reuters about the sale of UnitedHealth (NYSE:UNH)'s Brazilian health insurance operator Amil to Seripieri, who left Qualicorp in 2019. One of the sources had said Seripieri's bid was around 2.5 billion reais ($515.24 million).

In a regulatory filing on Friday, UnitedHealth said it will record a $7 billion charge related to the sale, a majority of which is non-cash and is being recorded due to foreign currency translation losses.

The charge will not impact UnitedHealth's adjusted earnings in 2024, the company said, confirming its adjusted profit forecast of $27.50 to $28.00 per share initially provided in November. UnitedHealth will report fourth-quarter 2023 results on January 12.

"We believe this agreement will ensure ongoing success, working with a buyer who has the local knowledge and experience to continue the positive momentum of the business," said UnitedHealth in an emailed statement.

UnitedHealth did not provide financial details about the transaction.

The healthcare firm said the sale includes Amil Insurance, Amil Integrated Care, Amil Dental and Americas Hospitals in Brazil.

Amil has 5.4 million health and dental insurance beneficiaries in Brazil and its sale was in the making for years, according to a Reuters report.

UnitedHealth CEO Andrew Witty announced the decision to sell Amil, acquired in 2012 for $5 billion, soon after taking the helm in 2021.

The company had previously struggled to sell its Brazilian unit due to antitrust issues and growing losses from individual health plans. It had suspended a sale process for Amil last year, according a Reuters report.

($1 = 4.8521 reais)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.